These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36331240)

  • 1. In-line monitoring of solid dispersion preparation in small scale extrusion based on UV-vis spectroscopy.
    Winck J; Daalmann M; Berghaus A; Thommes M
    Pharm Dev Technol; 2022 Dec; 27(10):1009-1015. PubMed ID: 36331240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
    Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
    Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of process temperature and residence time on the manufacturing of amorphous solid dispersions in hot melt extrusion.
    Gottschalk T; Grönniger B; Ludwig E; Wolbert F; Feuerbach T; Sadowski G; Thommes M
    Pharm Dev Technol; 2022 Mar; 27(3):313-318. PubMed ID: 35272581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
    Schittny A; Ogawa H; Huwyler J; Puchkov M
    Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
    Agrawal AM; Dudhedia MS; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the API dissolution rate during pharmaceutical hot-melt extrusion I: Effect of the API particle size, and the co-rotating, twin-screw extruder screw configuration on the API dissolution rate.
    Li M; Gogos CG; Ioannidis N
    Int J Pharm; 2015 Jan; 478(1):103-112. PubMed ID: 25448572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process analytical techniques for hot-melt extrusion and their application to amorphous solid dispersions.
    Hitzer P; Bäuerle T; Drieschner T; Ostertag E; Paulsen K; van Lishaut H; Lorenz G; Rebner K
    Anal Bioanal Chem; 2017 Jul; 409(18):4321-4333. PubMed ID: 28343348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Extrudable Form of Hypromellose: AFFINISOL™ HPMC HME.
    Huang S; O'Donnell KP; Keen JM; Rickard MA; McGinity JW; Williams RO
    AAPS PharmSciTech; 2016 Feb; 17(1):106-19. PubMed ID: 26335416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of process temperature and screw speed on properties of a pharmaceutical solid dispersion using corotating and counter-rotating twin-screw extruders.
    Keen JM; Martin C; Machado A; Sandhu H; McGinity JW; DiNunzio JC
    J Pharm Pharmacol; 2014 Feb; 66(2):204-17. PubMed ID: 24433423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
    J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-line solid state prediction during pharmaceutical hot-melt extrusion in a 12 mm twin screw extruder using Raman spectroscopy.
    Saerens L; Ghanam D; Raemdonck C; Francois K; Manz J; Krüger R; Krüger S; Vervaet C; Remon JP; De Beer T
    Eur J Pharm Biopharm; 2014 Aug; 87(3):606-15. PubMed ID: 24657540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.
    Bordos E; Islam MT; Florence AJ; Halbert GW; Robertson J
    Mol Pharm; 2019 Oct; 16(10):4361-4371. PubMed ID: 31436094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous production of itraconazole-based solid dispersions by hot melt extrusion: Preformulation, optimization and design space determination.
    Thiry J; Lebrun P; Vinassa C; Adam M; Netchacovitch L; Ziemons E; Hubert P; Krier F; Evrard B
    Int J Pharm; 2016 Dec; 515(1-2):114-124. PubMed ID: 27720874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holistic QbD approach for hot-melt extrusion process design space evaluation: Linking materials science, experimentation and process modeling.
    Evans RC; Bochmann ES; Kyeremateng SO; Gryczke A; Wagner KG
    Eur J Pharm Biopharm; 2019 Aug; 141():149-160. PubMed ID: 31132400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
    Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Poloxamer on the Dissolution and Stability of Hot-Melt Extrusion-Based Amorphous Solid Dispersions Using Design of Experiments.
    Shukla A; Dumpa NR; Thakkar R; Shettar A; Ashour E; Bandari S; Repka MA
    AAPS PharmSciTech; 2023 Apr; 24(5):107. PubMed ID: 37100926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic and robust assessment of hot-melt extrusion-based amorphous solid dispersions: Theoretical prediction to practical implementation.
    Alzahrani A; Nyavanandi D; Mandati P; Youssef AAA; Narala S; Bandari S; Repka M
    Int J Pharm; 2022 Aug; 624():121951. PubMed ID: 35753536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
    Tan DK; Davis DA; Miller DA; Williams RO; Nokhodchi A
    AAPS PharmSciTech; 2020 Nov; 21(8):312. PubMed ID: 33161479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.